Cintas CTAS
Industrials · Specialty Business Services · Synthos Deep Dive · 2026-08-04
The Overview
Cintas puts a driver in a van and sends him round the same route every week, delivering clean uniforms, floor mats and restroom supplies, and restocking first-aid cabinets and fire extinguishers. It is not glamorous and it is enormously profitable.
The reason is simple and it is worth understanding. The van and the driver cost the same whether they make ten stops or twenty. So the company with the most customers on any given street earns far more per route than anyone else. Cintas has been the biggest for decades, which means it keeps getting further ahead.
The results are almost monotonous. Revenue has risen every year for six years. Profit margin has risen every year for six years. Revenue has risen every quarter for nine quarters straight. The company earns about 42 cents of profit for every dollar of shareholders' money.
Something large is happening that standard data feeds have not registered. In March, Cintas agreed to buy UniFirst — the other big listed uniform-rental company in North America. The deal is waiting for competition-authority clearance. We cannot tell you what Cintas is paying, because no document we hold says. We can tell you it would remove the largest independent alternative for customers, which is exactly why competition authorities look at these things carefully.
And three days ago the company split the top job. Todd Schneider stays Chief Executive but is no longer President; Jim Rozakis, previously the operating chief, becomes President and Chief Operating Officer.
Now the problem, and it is the whole story: the shares cost $203.65, which is about 37 times what the company is expected to earn next year. For comparison, most of the other companies in this batch trade between 13 and 27 times. Cintas earns about 12% more each year. Paying 37 times for 12% growth means every penny of your return has to come from that growth — there is no cushion.
The company hands back about 88% of its spare cash, but because the shares are so expensive that only amounts to about 2% a year — a 0.88% dividend and a small buyback.
Our fair value estimate is $208, about 2% above the price. Analysts on average say $231.25, but here is the telling detail: of thirty analysts, 16 say hold and 2 say sell — the only company in this batch where the majority is not positive.
- Downside Risk 4/10. About as steady as businesses get — plus an unpriced antitrust review.
- Growth Quality 7/10. Immaculate and slowing gently: 12% now, not the "mid-to-high teens" our research base claims.
- Exponential Potential 2/10. A van, a route, and a very good spreadsheet.
Putting a number on it: our fair-value estimate is $208 against a current price of $204.18 — real upside if our numbers are right.
Our summary metrics
"Rated 4 — one of the most operationally stable businesses in this batch, carrying an unpriced regulatory risk and a demanding multiple. The supports are exceptional and consistent: revenue has grown every year for at least six, from $7,116.3M (FY2021) to $11,264.8M (FY2026); operating margin has expanded every single year, from 19.47% to 23.14%; return on equity is 41.8%, return on invested capital 23.4% and return on capital employed 33.2%; interest coverage is 24.5x; net debt of $2,416.9M is only 0.81x EBITDA; and a knowledge-base claim puts customer retention at 96% with a roughly 25-year customer life. The quarterly revenue series has risen sequentially in every one of the last nine quarters without exception. Against that, four exposures. ONE, the pending UniFirst merger, agreed 2026-03-10 and subject to Hart-Scott-Rodino clearance as of 2026-06-12 — a combination of the two largest independent uniform-rental operators in North America, whose antitrust outcome is unknowable from this archive and whose consideration is not disclosed in any document here. TWO, the price: 40.98x trailing earnings and 37.0x FY2027 consensus for a business growing earnings around 12%, with a free cash flow yield of 2.31% and a dividend of 0.88%. THREE, a management change three days old — the President and Chief Executive roles were separated effective 2026-08-01. FOUR, the knowledge base is unanimous and entirely from one episode twenty-two months old, so there is no independent voice arguing the other side of anything above."
"Rated 7 — steady, high-quality, entirely predictable, and slower than the knowledge base claims. Revenue: $7,116.3M (FY2021), $7,854.5M, $8,815.8M, $9,596.6M, $10,340.2M, $11,264.8M (FY2026) — a 9.6% compound rate over five years with growth of 10.4%, 12.2%, 8.9%, 7.7% and 8.9%. Diluted EPS: $2.56, $2.91, $3.25, $3.79, $4.40, $4.91 — a 13.9% compound rate. Operating margin has expanded in EVERY year: 19.47%, 20.21%, 20.45%, 21.56%, 22.82%, 23.14%. The quarterly sequence is the cleanest in this batch: $2,470.9M, $2,501.6M, $2,561.8M, $2,609.2M, $2,667.7M, $2,718.1M, $2,800.0M, $2,841.4M, $2,905.2M — nine consecutive sequential increases. Consensus wants revenue of $12,216.0M (FY2027, 15 analysts), $13,116.4M (FY2028, 14) and $14,047.8M (FY2029, 7) — 8.4%, 7.4% then 7.1% — with EPS of $5.497, $6.110 and $6.757, roughly 12.0% then 11.2% then 10.6%. What holds this at 7: the growth rate is decelerating gently at both the revenue and earnings line, and the knowledge base's central claim of 'mid-to-high teens' EPS growth is no longer being delivered — fiscal 2026 grew 11.6%. The pending UniFirst merger would change the revenue trajectory materially, but its size, price and probability are all absent from this archive."
"Rated 2 — a superb business with no exponential characteristic whatsoever, and the knowledge base explains precisely why it works. Cintas rents uniforms, mats and restroom supplies, and sells first-aid, safety and fire-protection services, delivered by drivers on fixed routes. The economics are route density: 'more stops and services per stop over fixed van/driver cost drives margin; scale compounds the advantage' (business_breakdowns, conviction 88). That is a real and durable advantage — it produces a 23.14% operating margin and a 33.2% return on capital employed — and it is also the definition of a linear business, because the growth rate is set by how many new stops can be added to existing routes. The runway is genuine and slow: one claim puts roughly half the North American uniform market as still insourced, which is a decades-long conversion opportunity rather than a curve. The four revenue lines — Uniform Rental and Facility Services $8,621.6M, First Aid and Safety $1,391.9M, Fire Protection $929.1M and Uniform Direct Sales $322.1M — are all mature service categories. The one genuinely non-linear event available is consolidation, and it is happening: the pending UniFirst merger would remove the largest independent competitor. That is a step change in scale, not a change in the nature of the business. A 2."
What does “fair value” mean?
Fair value is Synthos’s estimate of what one share is worth today, based on our model of the company’s future cash generation and the risks to it. It is not a price target or a prediction of where the stock trades next quarter — it’s the price where we think risk and reward are balanced. Above it, you’re paying for outcomes better than our base case; below it, the market is offering a margin of safety.
The model’s inputs and weightings are proprietary — they’re the product. What we publish is the output, plus an independent, public-math cross-check further down the page (“Check our number”) so you can judge it for yourself.
What do the 5 tiers mean? (Core · Tactical · Watch · Hold · Avoid)
The Road Ahead
What we expect to matter in each window, and the evidence that would prove us wrong.
Short term 0-6 months
Neutral- Driver
- "Cintas closed 2026-08-04 at $203.65, down 0.18% or $0.36, on 2,374,704 shares. It opened at $203.26, ranged $200.97 to $204.6689, and closed in the upper half. The stock has just had a very strong quarter: 22.0% in three months against SPY's 7.6%, the second-best three-month relative performance in this batch, taking it from 10.5% below its 50-day average to 10.5% above it. It now sits 10.0% below the 52-week high of $226.27 and 24.5% above the low of $163.55, with RSI at 61.6 and MACD at +7.41 — the most positive MACD reading in this batch. Twelve-month return is MINUS 8.1% against SPY's +24.3%, so the three-month rally has recovered part of a year of underperformance. The fundamental news is uniformly good and uniformly small: fourth-quarter results on 2026-07-15 beat consensus EPS by 4.0% ($1.29 against $1.24) and revenue by 1.1%, and the last five prints show EPS surprises of +1.9%, +0.8%, +0.8%, 0.0% and +4.0% — a company that beats by small, consistent amounts, which is exactly what a route-density business with 96% customer retention should do. The near-term uncertainty is not operational; it is the Hart-Scott-Rodino review of the UniFirst merger."
- What we’re watching
- "Any development on the UniFirst merger, agreed 2026-03-10 and still awaiting Hart-Scott-Rodino clearance as of the 8-K filed 2026-06-12. A second request, a consent decree requiring divestitures, or an abandonment would each move this stock more than any quarter will. NOTE that this archive contains NO disclosure of the consideration, the exchange ratio or the expected closing date — the 8-K describes only the structure — so the transaction cannot be sized here. Watch the 2026-09-23 first-quarter print against a consensus of $1.35 and $2,980.8 million, which would be the tenth consecutive sequential revenue increase. Watch whether operating margin extends its six-year run of annual expansion beyond 23.14%. And watch the new President and Chief Operating Officer, appointed 2026-08-01, for any change in operating cadence."
- Confidence
- Medium
Medium term 6-24 months
Tailwind- Driver
- "The medium-term operating case is close to mechanical and that is its virtue. Consensus has revenue at $12,216.0 million (FY2027), $13,116.4 million (FY2028) and $14,047.8 million (FY2029) — 8.4%, 7.4% and 7.1% — with EPS at $5.497, $6.110 and $6.757, roughly 12.0%, 11.2% and 10.6%. The estimate distribution is astonishingly tight: the FY2027 EPS range is $5.437 to $5.567, a 2.4% spread across 13 analysts, the narrowest in this batch by a wide margin. That tightness is itself the finding — the market has no disagreement whatever about what this company earns, which is the correct response to nine consecutive quarters of sequential revenue growth and six consecutive years of operating-margin expansion. The mechanism behind it is disclosed by the knowledge base rather than the filings: route density, roughly half the North American uniform market still insourced, and 96% customer retention. Capital return supports it modestly — $952.1 million of repurchases in fiscal 2026 (1.17% of market capitalisation) plus $701.5 million of dividends (0.88% yield) against free cash flow of $1,881.2 million, so 88% of cash generation is returned. And the UniFirst merger, if cleared, would add a step change in scale that no estimate in this file reflects."
- What we’re watching
- "Whether the UniFirst merger clears, and on what terms — the transaction is not sized anywhere in this archive and no estimate incorporates it. Whether operating margin can extend a six-year expansion run: from 19.47% to 23.14% is 367 basis points, and each further point is roughly $113 million of operating income. Whether EPS growth stabilises near 12% or continues decelerating from the 13.9% five-year compound rate — the knowledge base's central claim of 'mid-to-high teens' is already not being met. Whether the buyback continues near $950 million: the share count fell from 430.8 million to 406.2 million diluted over five years, a 1.2% annual reduction, which is a modest contributor. Whether the First Aid and Safety line, growing 14.3% to $1,391.9 million, and Fire Protection, growing 13.7% to $929.1 million, keep outpacing the core — they are the cross-selling thesis in the numbers. And whether the multiple holds: at 37.0x FY2027 consensus for 12% growth, the price-to-earnings-to-growth ratio is above 3."
- Confidence
- Medium
Long term 2+ years
Tailwind- Driver
- "Long-run this is one of the highest-quality compounding structures available in listed equity and the knowledge base describes it better than the filings do. Route-based services reward density above all else: each additional stop on an existing route carries almost no incremental cost, so the largest operator in a territory has a permanent margin advantage that widens with share. Cintas has converted that into a 23.14% operating margin, a 33.2% return on capital employed and — per an independent claim — a lead of roughly three to four times its peers' size and eight times their profit. The runway is unusually long because the competition is not other outsourcers but customers doing it themselves: roughly half the North American uniform market is still insourced. Retention of 96% implies a customer life near twenty-five years. And the family still owns roughly 14%, which historically correlates with long-horizon capital allocation. The pending UniFirst merger, if it clears, removes the largest independent alternative and extends the density advantage into territories Cintas does not dominate. What tempers the long view is entirely valuation and regulation: at 37x forward earnings for a 12%-growth business, a decade of compounding is already in the price, and a consolidation strategy that has reached the point of buying the number-two operator is a strategy approaching its regulatory limit."
- What we’re watching
- "Whether the antitrust environment permits further consolidation after UniFirst, because the acquisition runway is a component of the growth algorithm — $164.5 million and $232.9 million of bolt-on acquisitions in fiscal 2026 and 2025 sit alongside the pending merger. Whether the insourced half of the North American uniform market keeps converting at the historical rate. Whether First Aid and Safety and Fire Protection, the two fastest-growing lines, become large enough to change the group growth rate. Whether the family's roughly 14% holding persists and whether governance stays owner-operator in character; the separation of the President and Chief Executive roles on 2026-08-01 is the first structural change in some time. Whether the multiple compresses: a business earning 41.8% on equity deserves a premium, and the question for a ten-year holder is only how large. And whether any independent voice ever covers this company again — the entire knowledge-base lane is one episode from October 2024, and nothing in it post-dates the merger agreement."
- Confidence
- Medium
Exponential Potential
"Rated 2 — a superb business with no exponential characteristic whatsoever, and the knowledge base explains precisely why it works. Cintas rents uniforms, mats and restroom supplies, and sells first-aid, safety and fire-protection services, delivered by drivers on fixed routes. The economics are route density: 'more stops and services per stop over fixed van/driver cost drives margin; scale compounds the advantage' (business_breakdowns, conviction 88). That is a real and durable advantage — it produces a 23.14% operating margin and a 33.2% return on capital employed — and it is also the definition of a linear business, because the growth rate is set by how many new stops can be added to existing routes. The runway is genuine and slow: one claim puts roughly half the North American uniform market as still insourced, which is a decades-long conversion opportunity rather than a curve. The four revenue lines — Uniform Rental and Facility Services $8,621.6M, First Aid and Safety $1,391.9M, Fire Protection $929.1M and Uniform Direct Sales $322.1M — are all mature service categories. The one genuinely non-linear event available is consolidation, and it is happening: the pending UniFirst merger would remove the largest independent competitor. That is a step change in scale, not a change in the nature of the business. A 2."
What could take this further than the base case — and where the market may be underpricing it. Full forward-growth and acceleration math in Deeper analysis, §4 below.
Deeper analysis
Technicals, fundamentals, valuation, and the full expert-claim evidence panel — the detail behind the numbers above.
Reference table
| Street consensus | $231.25 (+13.6%) · median $230.50 · high $250 (+22.8%) · low $214 (+5.1%, above spot) · 12 buy / 16 hold / 2 sell across 30 analysts — consensus rating "Hold" |
| Valuation | 40.98x trailing EPS of $4.91 · 37.0x FY2027E $5.497 · 33.3x FY2028E $6.110 · 30.1x FY2029E $6.757 · 7.23x sales · 15.86x book |
| The transaction the payload has never heard of | An Agreement and Plan of Merger with UNIFIRST CORPORATION, entered 2026-03-10, through Bruin Merger Sub I, Inc. and Bruin Merger Sub II, LLC, subject to Hart-Scott-Rodino clearance and still pending as of the 8-K filed 2026-06-12. No consideration, exchange ratio or expected closing date is disclosed in this archive |
| Cash generation — recomputed, and verified | FY2026 operating cash flow $2,276.3M less filed capital expenditure $395.1M = free cash flow $1,881.2M, a 2.31% yield. The 10-K states capital expenditure of $395.1M and $408.9M for fiscal 2026 and 2025 in prose AND in the statement — matching the vendor exactly across three years |
| The operating record | Revenue up every year for six: $7,116.3M → $11,264.8M. Operating margin up every year: 19.47% → 23.14%. Nine consecutive quarters of sequential revenue growth. Return on equity 41.8%, return on invested capital 23.4%, return on capital employed 33.2% |
| Balance sheet | Total debt $2,706.0M (of which $277.9M is lease obligations — a 10.3% inclusion) · cash $289.0M · net debt $2,416.9M, 0.81x EBITDA · interest coverage 24.5x |
| Capital return | Buyback $952.1M (1.17% of market capitalisation) plus dividends $701.5M (0.88% yield) = 88% of free cash flow returned. Total shareholder yield ~2.05% |
| Conviction | Unanimous, high, and 100% SINGLE-SOURCE — 7 raw KB hits, 7 surviving a case-sensitive re-run, 0 discarded, ALL SEVEN from one episode dated 2024-10-22. Four are now testable: two CONFIRMED, one PARTIALLY FALSIFIED, one overtaken by the merger |
| Technicals | −10.0% from the 52-week high of $226.27; +24.5% above the low of $163.55; +10.5% above the 50-DMA ($184.22) and +10.0% above the 200-DMA ($185.09); RSI 61.6; MACD +7.41 — the most positive in this batch; 3-month +22.0% vs SPY +7.6% but 12-month −8.1% vs SPY +24.3% |
What the experts actually said 7 traceable claims on CTAS · showing the highest-conviction voices
“Cintas is a durable high-quality compounder growing EPS mid-to-high teens via scale, density, and cross-selling; among best S&P 500 returns.”
Every claim reconciles to a real claim_id in the Synthos knowledge base — this is the evidence the verdict is built on, not vibes. Management (the company itself) is shown but half-weighted; one cautionary voice is included on purpose.
Price & moving averages 12 months · 50 & 200-day averages · 52-week range
Solid line = price · dashed line = 50-day average · dotted line = 200-day average · the two thin horizontal lines mark the 52-week high and low. Price above both averages is an uptrend.
Data summary: last close $204.18, 5% above the 50-day average ($194), 9% above the 200-day average ($186) — an uptrend. 6% below the 52-week high of $217, 25% above the 52-week low of $164.
Bollinger Bands 20-day average ± 2 standard deviations
The shaded band widens when the stock gets more volatile. Riding the upper edge = strong momentum (sometimes stretched); the lower edge = weak / potentially oversold.
Data summary: price $204.18 is currently inside the band (band $199–$207).
RSI (14) momentum gauge · 0–100
Above 70 (overbought zone, shaded) = overbought, below 30 (oversold zone, shaded) = oversold. Currently 55.
MACD 12 / 26 / 9 · trend & momentum
The MACD line crossing above the signal line (bars flip to the up color) = momentum turning up; crossing below (bars flip to the down color) = turning down. Bar height = the size of that gap.
Data summary: MACD is currently below its signal line by 0.46, negative momentum.
Relative performance vs S&P 500 & its sector (XLI (sector)), set to 100 a year ago
Solid = CTAS · dashed = S&P 500 · dotted = XLI (sector). A rising line means it is beating that benchmark — the sector line shows whether it is a leader or laggard within its own group.
Forward revenue & earnings actual → estimate · "FY" = fiscal year, "E" = estimate
Darker bars = actual results, brighter = analyst estimates. Taller bars to the right = expected growth.
Key stats an RIA wants
1. The operating record, which is the reason to care
Six years, and every line goes the right way:
| Fiscal year | Revenue | growth | Operating income | Op. margin | Diluted EPS | Diluted shares (M) |
|---|---|---|---|---|---|---|
| FY2021 | $7,116.3M | — | $1,385.5M | 19.47% | $2.56 | 430.8 |
| FY2022 | $7,854.5M | +10.4% | $1,587.4M | 20.21% | $2.91 | 422.1 |
| FY2023 | $8,815.8M | +12.2% | $1,802.7M | 20.45% | $3.25 | 413.5 |
| FY2024 | $9,596.6M | +8.9% | $2,068.6M | 21.56% | $3.79 | 413.5 |
| FY2025 | $10,340.2M | +7.7% | $2,359.7M | 22.82% | $4.40 | 410.3 |
| FY2026 | $11,264.8M | +8.9% | $2,606.5M | 23.14% | $4.91 | 406.2 |
Revenue up every year. Operating margin up every year. Share count down every year. Diluted EPS compounding 13.9%. That is six clean years and there is no accounting distortion anywhere in it — no restructuring, no impairment, no tax-benefit swing of the kind that distorts three other names in this batch.
The quarterly record is if anything more striking:
| Quarter | Revenue | sequential | Operating income | Op. margin | Diluted EPS |
|---|---|---|---|---|---|
| Q4 FY2024 | $2,470.9M | — | $547.6M | 22.16% | $1.00 |
| Q1 FY2025 | $2,501.6M | +1.2% | $561.0M | 22.43% | $1.10 |
| Q2 FY2025 | $2,561.8M | +2.4% | $591.4M | 23.08% | $1.09 |
| Q3 FY2025 | $2,609.2M | +1.9% | $609.9M | 23.37% | $1.13 |
| Q4 FY2025 | $2,667.7M | +2.2% | $597.5M | 22.40% | $1.09 |
| Q1 FY2026 | $2,718.1M | +1.9% | $617.9M | 22.73% | $1.20 |
| Q2 FY2026 | $2,800.0M | +3.0% | $655.7M | 23.42% | $1.21 |
| Q3 FY2026 | $2,841.4M | +1.5% | $659.9M | 23.22% | $1.24 |
| Q4 FY2026 | $2,905.2M | +2.2% | $673.0M | 23.17% | $1.26 |
Nine consecutive sequential increases in revenue, with no quarter below +1.2% and none above +3.0%. This is the least volatile operating series in this batch and it is what a 96% customer-retention business looks like from the outside.
Revenue by line, and seg_prod sums to revenue to the dollar:
| Line | FY2026 | share | FY2025 | YoY |
|---|---|---|---|---|
| Uniform Rental and Facility Services | $8,621.6M | 76.5% | $7,976.1M | +8.1% |
| First Aid and Safety Services | $1,391.9M | 12.4% | $1,218.1M | +14.3% |
| Fire Protection Services | $929.1M | 8.2% | $817.5M | +13.7% |
| Uniform Direct Sales | $322.1M | 2.9% | $328.6M | −2.0% |
| Total | $11,264.8M | 100.0% | $10,340.2M | +8.9% |
$11,264,761,000 against inc_a revenue of $11,264,761,000 — exact. And the cross-selling thesis is visible: First Aid and Safety grew 14.3% and Fire Protection 13.7%, both roughly 70% faster than the core rental business, which is precisely the "more services per stop" mechanism a knowledge-base claim describes.
2. The merger the payload has never heard of
From the 8-K filed 2026-06-12:
> "As previously disclosed, on March 10, 2026, Cintas Corporation, a Washington corporation ('Cintas'), entered into an Agreement and Plan of Merger (the 'Merger Agreement') with (i) UniFirst Corporation, a Massachusetts corporation ('UniFirst'), (ii) Bruin Merger Sub I, Inc., a Delaware corporation and a wholly owned subsidiary of Cintas ('Merger Sub Inc.'), and (iii) Bruin Merger Sub II, LLC, a Delaware limited liability company and a wholly owned subsidiary of Cintas ('Merger Sub LLC'). The Merger Agreement provides, among other things, that subject to the satisfaction or waiver of the conditions set forth therein, including the expiration or termination of the applicable waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended (the 'HSR Act'), (i) Merger Sub Inc. will be merged with and into UniFirst (the 'First Merger')... and (ii) immediately after the First Merger, UniFirst will be merged with and into Merger Sub LLC (the 'Second [Merger]')."
Four things follow, and the fourth is the important one.
First, this is the largest corporate action in this dive and NOTHING about it appears in the vendor payload. bal_a, cf_a and inc_a all end at 2026-05-31; no estimate row reflects it; peers does not even list UniFirst.
Second, it is a horizontal combination of the two largest independent listed uniform-rental operators in North America. A knowledge-base claim from October 2024 names UniFirst explicitly as one of the peers Cintas had out-grown — 'Cintas widened its lead to ~3-4x peers' size and ~8x their profit... while Vestis/Aramark stayed over-levered' — so the store's own framing of the competitive landscape has been overtaken by Cintas buying one of the named comparators.
Third, the structure is a two-step reverse-triangular merger followed by an upstream merger into a limited liability company — a standard tax-efficient structure for a cash or stock acquisition of a public target — and the conditionality named is the Hart-Scott-Rodino waiting period. That is an antitrust condition and it is the operative one: combining the number one and number two operators in a route-density business invites exactly the analysis that competition authorities perform.
Fourth, and this is the limitation this dive must state: NO consideration, exchange ratio, expected closing date, financing arrangement or termination fee is disclosed in any document in this archive. The 8-K describes the structure and the pending condition and nothing else. This dive therefore CANNOT size the transaction, cannot assess its accretion, and does not embed any completion assumption in any fair-value anchor. What it can say is that the largest identified risk and the largest identified opportunity on this name are the same event, and that neither the payload nor the archive quantifies it.
One further corporate action, three days old. From the 8-K filed 2026-08-03:
> "On July 28, 2026, in connection with Cintas Corporation's decision to separate the roles of President and Chief Executive Officer, the Company appointed Jim Rozakis, currently Executive Vice President and Chief Operating Officer, as President and COO, effective August 1, 2026. As a result, Todd Schneider will remain as the Company's Chief Executive Officer and will no longer hold the title of President."
Mr Rozakis's compensation is disclosed: base salary $900,000, target annual cash incentive $1,125,000, target long-term incentive $4,000,000. Separating the President and Chief Executive titles and elevating the operating chief is, in most cases, succession architecture. The filing does not describe it as such and this dive does not assert it — but on a company with a pending transformational merger it is worth recording that the operating leadership changed three days before this dive.
3. Cash generation — and a clean capex check
The 10-K states the capital-expenditure figures twice, in prose and in the cash flow statement, and both match the vendor exactly:
> "Capital expenditures were $395.1 million and $408.9 million for fiscal 2026 and fiscal 2025, respectively. Capital expenditures for fiscal 2026 included $279.4 million for the Uniform Rental and Facility Services reportable operating segment and $59.0 million for the First Aid and Safety Services reportable operating segment."
| Fiscal year | Operating cash flow | Capex — vendor | Capex — filed | Free cash flow |
|---|---|---|---|---|
| FY2024 | $2,079.8M | $409,469K | $409,469K | $1,670.3M |
| FY2025 | $2,165.9M | $408,884K | $408,884K | $1,757.0M |
| FY2026 | $2,276.3M | $395,105K | $395,105K | $1,881.2M |
Exact across all three years, in the statement and in prose. The diagnostic passes too: capexToDepreciationTTM of 0.770 against a direct computation of $395.1M / $512.8M = 0.771. Neither the datum nor the diagnostic is corrupt, and this is reported as a finding because 40.9% of payloads in this programme fail it.
Free cash flow of $1,881.2M is a 2.31% yield and freeCashFlowYieldTTM of 2.308% agrees exactly. That is the second-lowest free cash flow yield in this batch, and it is low because the price is high, not because the cash generation is weak — free cash flow has grown every year, from $1,266.7M in fiscal 2023 to $1,881.2M in fiscal 2026, a 14.1% compound rate.
Capital return, and the payout ratio is disciplined:
| FY2024 | FY2025 | FY2026 | |
|---|---|---|---|
| Free cash flow | $1,670.3M | $1,757.0M | $1,881.2M |
| Share repurchases | $700.0M | $934.8M | $952.1M |
| Dividends | $530.9M | $611.6M | $701.5M |
| Total returned | $1,230.9M | $1,546.4M | $1,653.6M |
| as % of free cash flow | 73.7% | 88.0% | 87.9% |
| Acquisitions | $186.8M | $232.9M | $164.5M |
Roughly 88% of free cash flow returned, with the balance funding bolt-on acquisitions. dividendPerShareTTM of $1.80 is a 0.88% yield; the buyback of $952.1M is 1.17% of market capitalisation; total shareholder yield is approximately 2.05% — the lowest in this batch bar one.
Balance sheet. Total debt of $2,706.0M includes $277.9M of lease obligations — a 10.3% inclusion — so filed financial debt is approximately $2,428.1M against $289.0M of cash. Net debt of $2,416.9M is 0.81x EBITDA, and interestCoverageRatioTTM is 24.5x. A knowledge-base claim from 2024 credits Cintas with a 'disciplined ~1x net-debt balance sheet'; at 0.81x, that claim is CONFIRMED.
4. Valuation
At $203.65:
| FY2026 (actual) | FY2027E | FY2028E | FY2029E | |
|---|---|---|---|---|
| Revenue | $11,264.8M | $12,216.0M (15) | $13,116.4M (14) | $14,047.8M (7) |
| Revenue growth | +8.9% | +8.4% | +7.4% | +7.1% |
| EPS | $4.91 | $5.497 (13) | $6.110 (12) | $6.757 (5) |
| EPS growth | +11.6% | +12.0% | +11.2% | +10.6% |
| P/E | 40.98x | 37.0x | 33.3x | 30.1x |
| EPS range | — | $5.437–$5.567 | $5.970–$6.300 | $6.318–$7.029 |
| range as % of mean | — | 2.4% | 5.4% | 10.5% |
The FY2027 EPS range of 2.4% across 13 analysts is the tightest forward distribution in this batch by a very wide margin — the next narrowest is 3.9%, and one name in this batch has a 98% spread. That is not a coverage artefact; it is thirteen analysts agreeing almost exactly about a company that has beaten by +1.9%, +0.8%, +0.8%, 0.0% and +4.0% over the last five quarters. On this name, forward estimates can be trusted more than on any other in the batch.
est.ebitdaAvg and est.ebitAvg are rejected for the fixed-ratio fabrication signature. ebitdaAvg is exactly 31.22% of revenueAvg and ebitAvg exactly 27.10% in FY2024, FY2025, FY2026, FY2027, FY2028, FY2029 and FY2030 — seven consecutive years. The implied EBITDA margin of 31.22% is 4.7 points above the reported ebitdaMarginTTM of 26.56%. Note that the FY2023 row breaks the pattern at 21.10%, so the fabrication begins in FY2024. All valuation uses epsAvg.
4a. What today's price assumes (the inversion)
At $203.65 — 40.98x trailing, 37.0x FY2027 consensus, a 2.31% free cash flow yield — the price embeds:
- EPS reaches $5.497 in fiscal 2027 and $6.110 in fiscal 2028. (Consensus; 13 and 12 analysts, with a 2.4% FY2027 spread.) This is the least fragile assumption in this batch.
- Operating margin keeps expanding beyond 23.14%. (Our derivation.) It has risen in each of six years by an average of 73 basis points. Consensus EPS growth of 12% on revenue growth of 8.4% requires roughly 60 basis points more, which is exactly the historical rate — so the price assumes the streak continues.
- The market keeps paying 33–41x forward earnings. (Our number.) This is the most fragile assumption in the price. The observed twelve-month range on the FY2028 estimate is 26.8x at the 52-week low of $163.55 and 37.0x at the high of $226.27 — the price sits near the top of it, after a 22.0% three-month rally.
- The UniFirst merger either clears without material remedy, or is abandoned without cost. (Our number; nothing in this archive sizes it.) The price contains no visible discount for antitrust risk and no visible premium for accretion, because the transaction is not quantified anywhere.
- Capital return stays near 2%. (Our number.) At 88% of free cash flow already returned, there is no headroom without leverage.
4b. The return bridge (why the multiple moves)
Expected return over the next twenty-four months decomposes as: EPS growth (+24.4% cumulative, from FY2027E $5.497 to FY2029E $6.757) + multiple drift (COMPRESSION, from 37.0x to roughly 34x on the then-forward year) + shareholder yield (+2.05% per year) ≈ +8% to +11% a year.
Our base of $208 applies 34.0x FY2028E — a compression from today's 37.0x — and the arithmetic is unusually clean because the estimates are unusually tight. At an unchanged 37.0x the fair value is $226, +11.0%; at 30x it is $183, −10.1%. The entire question on this name is the multiple, and the answer is not knowable from the filings.
Note what makes this different from the other Holds in this batch: there is nothing wrong with the business, no data defect of consequence, no unresolved disclosure gap except the merger, and no bearish independent voice. The verdict is a price judgement and nothing else, and it is stated that plainly.
4c. Variant perception (where we differ, what would surprise)
- We are 10.2% below the street's $231.25 and the difference is entirely the multiple. But note the composition of that consensus: 12 buy, 16 HOLD, 2 SELL — the only Hold-rated name in this batch. The average target implies +13.6% while the majority of analysts decline to recommend it, which is an internally inconsistent consensus and is worth noticing.
- We think the knowledge base's central claim is quietly out of date and we grade it. "Growing EPS mid-to-high teens" (conviction 90, 2024-10-22) has become 11.6% delivered in fiscal 2026 and 12.0% then 11.2% in consensus. The five-year compound rate of 13.9% is at the bottom of "mid-teens" and the forward rate is below it. Watchable number: fiscal 2027 EPS growth against 12.0%. A return to 15%+ would validate the claim and the multiple; continued deceleration toward 10% would not.
- We think the UniFirst merger is the dominant variable and is unpriced in both directions, because no document in this archive sizes it. A clean clearance would add scale to the highest-return route business in the industry; a second request or a divestiture remedy would consume management attention for a year. We embed neither.
- Positive surprise that would force a re-rate: Hart-Scott-Rodino clearance without remedy; a seventh consecutive year of operating-margin expansion above 24%; or First Aid and Fire Protection sustaining 14% growth to become a fifth of revenue.
- Negative surprise that would break the thesis: a second request or litigation on the UniFirst merger; the first sequential revenue decline in ten quarters; operating margin flat or down year on year for the first time in six years; or EPS growth below 10%.
Synthos fair values
All three anchors are multiples of the FY2028 consensus EPS distribution (mean $6.11011, low $5.96988, high $6.30042, 12 analysts), cross-checked against the observed twelve-month multiple range of 26.8x–37.0x.
- Bear ~$155 — 26.0x the FY2028 consensus LOW of $5.970, roughly the multiple paid at the 52-week low. Cross-check: 5.2% below that low of $163.55; 28.2x FY2027E; a 3.03% free cash flow yield. The scenario: the UniFirst merger fails or is remedied expensively, margin expansion stalls, EPS growth decelerates below 10%, and a 37x multiple compresses toward the low end of its own annual band. −23.9%.
- Base ~$208 — 34.0x the FY2028 consensus MEAN of $6.110. Cross-check: 37.8x FY2027E; 30.8x FY2029E; 10.2% below the street's $231.25; 8.1% below the 52-week high. The scenario: the operating record continues exactly as it has for six years, EPS compounds near 12%, and the multiple gives back three of the eleven turns it gained in the three-month rally. +2.1%.
- Bull ~$252 — 40.0x the FY2028 consensus HIGH of $6.300. Cross-check: 11.4% above the 52-week high of $226.27; 45.8x FY2027E; 0.8% above the street's high target of $250. The scenario: the merger clears cleanly and adds scale, margin expansion reaccelerates, and the market pays a full quality premium for the most predictable compounder in the sector. +23.7%.
Base is 2.1% above spot; asymmetry roughly 0.99:1 (23.9% down, 23.7% up), plus a shareholder yield of 2.05%. A base of 2% and a payoff ratio of one-to-one is not a Buy and it is not a Watch either, because there is no trigger to wait for other than a lower price. It is a Hold: a business worth owning if owned, at a price that offers no reason to start.
5. Knowledge base — seven claims, one episode, and four now testable
Raw hits: 7. After a case-sensitive entity re-run: 7. Discarded: 0. Homograph collisions: 0. Channels: ONE.
The sweep ran CTAS, Cintas and Cintas Corporation plus free text on "cintas" and "uniform rental" across all 52,021 distilled claims.
THE CONCENTRATION IS TOTAL AND MUST BE STATED FIRST. All seven claims come from a single business_breakdowns episode dated 2024-10-22. Remove that one episode and the lane is EMPTY. No concentration sensitivity test is possible on this name — there is nothing to test against — and no claim in the store post-dates the UniFirst merger agreement of 2026-03-10 or anything else that has happened in the last twenty-two months.
The seven, all bullish:
> conviction 90 · thesis — "Cintas is a durable high-quality compounder growing EPS mid-to-high teens via scale, density, and cross-selling; among best S&P 500 returns."
> conviction 88 · principle — "In route-based services, local density is decisive: more stops and services per stop over fixed van/driver cost drives margin; scale compounds the advantage."
> conviction 85 · thesis — "Long growth runway: ~half of North American uniform market still insourced, so Cintas keeps converting greenfield customers without competing on price."
> conviction 85 · thesis — "Cintas widened its lead to ~3-4x peers' size and ~8x their profit via disciplined ~1x net-debt balance sheet while Vestis/Aramark stayed over-levered."
> conviction 85 · principle — "Over-50% return on operating assets combined with consistent reinvestable growth is a powerful wealth-creation engine; high ROA only matters when paired with growth."
> conviction 80 · thesis — "Culture and service quality drive 96% retention (~25-year customer life), far above peers' 85-90%, creating durable switching costs and pricing power."
> conviction 78 · thesis — "Family still owns ~14%; management responds transparently to mistakes (document management exit, fire-inspection insourcing) and absorbs inflation before raising prices."
Four are testable against the filings. We grade them.
> "Growing EPS mid-to-high teens" (conviction 90)
>
> VERDICT: PARTIALLY FALSIFIED, and this is the most important grade in the lane. Diluted EPS grew 11.6% in fiscal 2026 ($4.40 to $4.91) and compounded 13.9% over five years — at the bottom of "mid-teens" historically and below it forward, with consensus at 12.0% then 11.2% then 10.6%. The claim was made in October 2024 and describes a growth rate the company is no longer delivering. At 37.0x forward earnings that distinction matters more than any other in this dive.
> "Disciplined ~1x net-debt balance sheet" (conviction 85)
>
> VERDICT: CONFIRMED. Net debt of $2,416.9M against trailing EBITDA of approximately $2,991M is 0.81x, and interest coverage is 24.5x.
> "Over-50% return on operating assets... a powerful wealth-creation engine" (conviction 85)
>
> VERDICT: CONFIRMED on the spirit if not the exact metric. returnOnAssetsTTM is 19.0% on total assets including $3,544M of goodwill, but returnOnTangibleAssetsTTM is 29.9%, operatingReturnOnAssetsTTM is 25.1%, returnOnCapitalEmployedTTM is 33.2% and returnOnEquityTTM is 41.8%. The 50%+ figure is presumably struck on operating assets excluding goodwill and cash, which this file does not compute — but the returns are unambiguously exceptional and the claim's conclusion holds.
> "Cintas widened its lead to ~3-4x peers' size and ~8x their profit... while Vestis/Aramark stayed over-levered" (conviction 85)
>
> VERDICT: OVERTAKEN BY EVENTS, and in a way that cuts both directions. The claim names UniFirst as one of Cintas's peers. Cintas agreed to BUY UniFirst on 2026-03-10. That validates the scale thesis — the leader is now consolidating the runner-up — and simultaneously introduces an antitrust risk that no claim in this lane addresses, because the lane predates the transaction by seventeen months.
The remaining three — route density, the insourced runway, and 96% retention — are structural descriptions this dive cannot independently verify from the filings, because Cintas does not publish retention or market-share data in any document in this archive. They are cited for the mechanism they describe and are labelled unverified.
Attribution. All seven carry speaker: null and are attributed only to a channel — the weakest sourcing the four-lane policy admits, applied to the entire lane. No claim is management voice. No claim is bearish. No claim post-dates 2024-10-22.
Conclusion. Breadth 7 claims but ONE channel and ONE episode, claim count 7, net conviction unanimous-positive and structurally unreliable as a check. A lane that agrees with itself completely, comes from a single source, and is twenty-two months old cannot function as a counterweight to the filings — and on a name whose only real question is valuation, it offers no opinion at all.
6. Data integrity
Five findings: two clean checks and three defects. Cintas has one of the cleanest payloads in this batch.
CLEAN 1 — capital expenditure and operating cash flow verify EXACTLY against the 10-K across three years, and the figure is stated twice. Vendor capex of $409,469K / $408,884K / $395,105K against the 10-K's cash flow statement figures of $409,469K / $408,884K / $395,105K, and against the prose statement "Capital expenditures were $395.1 million and $408.9 million for fiscal 2026 and fiscal 2025." capexToDepreciationTTM of 0.770 reconciles to a direct 0.771, and freeCashFlowYieldTTM of 2.308% reconciles exactly to our recomputation. Both the datum and the diagnostic pass.
CLEAN 2 — seg_prod sums to revenue TO THE DOLLAR. $8,621,624K + $1,391,853K + $929,142K + $322,142K = $11,264,761,000 against inc_a FY2026 revenue of $11,264,761,000. The over-counting defect is absent. Note a taxonomy change: the FY2024 block uses only two lines ("Other Products And Services" $2,131,416K and "Uniform Rental and Facility Services" $7,465,199K) which also sum to revenue exactly, so the block is internally consistent in both taxonomies but not comparable across the FY2024 boundary.
DEFECT 1 — seg_geo is an EMPTY ARRAY. No geographic revenue disclosure of any kind. Cintas operates in the United States, Canada and Latin America per its own description, and the payload provides no split. This is the truncation defect and it is reported as an absence rather than filled in; no geographic analysis appears anywhere in this dive.
DEFECT 2 — inc_q reports ZERO depreciation and amortisation for the fourth quarter of fiscal 2026. The three preceding quarters read $125,937K, $127,501K and $128,670K, and cf_a reports $512,846K for the full year. The June quarter should be approximately $130,738K. The field is rejected for that quarter and no quarterly EBITDA is computed.
DEFECT 3 — est.ebitdaAvg and est.ebitAvg carry the fixed-ratio fabrication signature across SEVEN consecutive years. ebitdaAvg is exactly 31.22% of revenueAvg and ebitAvg exactly 27.10% in FY2024 through FY2030. The implied EBITDA margin is 4.7 points above the reported ebitdaMarginTTM of 26.56%. The FY2023 row breaks the pattern at 21.10%, which dates the onset of the fabrication. Rejected; all valuation uses epsAvg.
Also noted: totalDebt of $2,706.0M includes $277.9M of lease obligations — a 10.3% inclusion, giving filed financial debt of approximately $2,428.1M; the effect on net leverage is immaterial (0.81x becomes 0.72x) and both are stated. researchAndDevelopmentExpenses reads $0 for fiscal 2026 after $30.8M, $26.6M, $24.5M, $23.5M and $22.3M in the five preceding years — a field that went to zero rather than a company that stopped spending, and it is rejected. km_ttm and ratios_ttm are present and complete. quote.yearHigh/yearLow ($226.75/$161.16) against tech.hi52/lo52 ($226.27/$163.55), a 0.2% and 1.5% discrepancy; tech is used throughout. The implied share count of 400,169,977 against inc_q's 404,307,000 weighted diluted is a 1.0% gap, consistent with a continuing buyback.
Vendor composite rating — noted. B+ / 3 overall, with 5 out of 5 on both return on equity and return on assets, and 1 out of 5 on price-to-book and 2 on price-to-earnings. The block reaches this dive's conclusion by a different route: the returns are outstanding and the price is not.
Non-equity tripwire — checked and passed. CTAS is common stock, Nasdaq-listed since 1983-08-19. Price of $203.65 is not par-like; beta is 0.933; the dividend is variable; volume was 2.37M shares (roughly $484M of turnover); the 52-week band of $163.55 to $226.27 is a 38% range. This is common equity.
7. Technicals
- Price $203.65, down 0.18% on 2,374,704 shares. Opened $203.26, ranged $200.97 to $204.6689.
- −10.0% from the 52-week high of $226.27; +24.5% above the low of $163.55. Position within the annual range: 64th percentile.
- Above both moving averages by almost identical margins: +10.5% above a 50-day average of $184.22 and +10.0% above a 200-day average of $185.09, with the two averages within 0.5% of each other. That configuration — a flat long-term trend with price 10% above it — is a stock that has just broken out of a range.
- RSI 61.6 — strong, not overbought. MACD +7.41 — the most positive reading in this batch.
- Maximum drawdown from peak over the trailing year: −10.5% — the second-shallowest in this batch.
- Relative performance: 3-month +22.0% against SPY +7.6% and QQQ +7.7% — outperforming by 14 points, the second-best in this batch; 6-month +6.7% against SPY +11.1%; 12-month −8.1% against SPY +24.3% and QQQ +30.8%. A year of underperformance reversed decisively in one quarter, which is why the multiple is back near the top of its band.
- Sentiment: 12 buy, 16 hold, 2 sell across 30 analysts; the vendor's own consensus label is "Hold" — the only one in this batch; consensus target $231.25 (+13.6%), median $230.50, high $250, low $214 — 5.1% ABOVE spot. A consensus in which the majority declines to recommend the stock while the average target implies +13.6% is internally inconsistent, and this dive weights the ratings above the targets.
Today's move and what it does to the entry
CTAS closed 2026-08-04 at $203.65, down $0.36, on the second-lightest volume in this batch. There is no company-specific filing dated 2026-08-04; the most recent is the 8-K of 2026-08-03 announcing the President and Chief Operating Officer appointment.
The honest read: this is not an entry. The stock has risen 22.0% in three months, sits 10% above both moving averages and 10% below its high, and the base case is +2.1%. Nothing about the business argues against owning it; everything about the price argues against buying it today.
8. Insiders — mechanical, with one director sale
| Date | Person | Role | Type | Shares | Price | Held after |
|---|---|---|---|---|---|---|
| 2026-07-16 | Melanie W. Barstad | director | M-Exempt (A) | 10,548 | $27.10 | 37,140 |
| 2026-07-22 | Ronald W. Tysoe | director | M-Exempt (A) | 5,048 | $27.10 | 27,496 |
| 2026-07-22 | Ronald W. Tysoe | director | F-InKind | 685 | $199.90 | 26,811 |
| 2026-07-22 | Ronald W. Tysoe | director | S-Sale | 4,363 | $199.90 | 22,448 |
| 2026-07-22 | Ronald W. Tysoe | director | M-Exempt (D) | 5,048 | $27.10 | 0 |
| 2026-07-28 | Melanie W. Barstad | director | A-Award | 148.32 | $0 | 4,734.45 |
| 2026-07-28 | Karen L. Carnahan | director | A-Award | 133.78 | $0 | 6,815.81 |
| 2026-07-28 | Robert E. Coletti | director | A-Award | 116.33 | $0 | 11,363.14 |
The reading, and it is close to signal-free. Every transaction belongs to a non-employee director. Three are quarterly A-Award accruals of 116 to 148 shares at zero price — dividend-equivalent credits with no informational content. Two are option exercises at a strike of $27.10, an eighty-six percent discount to the market price and therefore options at least a decade old.
The one decision: Ronald W. Tysoe sold 4,363 shares at $199.90 on 2026-07-22, having exercised 5,048 options at $27.10 the same day and surrendered 685 to tax. This is a textbook exercise-and-sell — he monetised 86% of the exercised block and retains 22,448 shares, approximately $4.6 million. It was executed 1.8% below today's price.
Melanie W. Barstad exercised 10,548 options at $27.10 on 2026-07-16 and did NOT sell, taking her holding to 37,140 shares — approximately $7.6 million. That is the more interesting of the two, and it is mildly favourable.
What the file does not contain: any transaction by Todd Schneider, the chief executive, by Jim Rozakis, the new President and Chief Operating Officer, or by any member of the founding family holding roughly 14% per the knowledge base. The insider block for Cintas is uninformative and is scored as such.
9. Verdict, kill-criteria and flip conditions
Hold.
This is a Hold for one reason and it is not a criticism of the company. Cintas has grown revenue in each of the last six years and expanded its operating margin in each of the last six years, has posted nine consecutive quarters of sequential revenue growth, earns 41.8% on equity, 23.4% on invested capital and 33.2% on capital employed, carries 0.81x net leverage with 24.5x interest coverage, verifies its capital-expenditure line exactly against three filed years, and reports a segment block that ties to revenue to the dollar. There is no data defect of consequence, no accounting distortion, no unresolved disclosure gap except the merger, and not one bearish independent voice anywhere in 52,021 knowledge-base claims.
At $203.65 it trades at 40.98x trailing earnings and 37.0x the FY2027 consensus of $5.497, for roughly 12% earnings growth, a 2.31% free cash flow yield and a 0.88% dividend, after a 22.0% three-month rally. Our base of $208 is 2.1% above spot with 0.99:1 asymmetry.
Three specific observations that support the tier rather than hedge it.
First, the knowledge base's central claim is out of date and we graded it. "Growing EPS mid-to-high teens" has become 11.6% delivered and roughly 12% consensus. A 37x multiple was earned by mid-teens growth; low-teens growth does not sustain it indefinitely.
Second, the largest variable is not in any document we hold. The UniFirst merger, agreed 2026-03-10 and pending Hart-Scott-Rodino clearance, is unsized: no consideration, no exchange ratio, no closing date, no financing. It could be the most value-accretive act in the company's history or a year of regulatory litigation, and this archive cannot distinguish.
Third, the sell side has reached the same conclusion by a different route. Twelve buy, sixteen hold, two sell — the only Hold-rated consensus in this batch — while the average price target implies +13.6%. Where analyst ratings and analyst targets disagree, the ratings are the honest signal.
Pre-registered KILL criteria — what would take this to Watch or Avoid:
- The first sequential revenue decline in ten quarters.
- Operating margin flat or down year on year, ending a six-year expansion run.
- EPS growth below 10% in any fiscal year, against 11.6% delivered and 12.0% consensus.
- A second request, litigation or a divestiture remedy on the UniFirst merger, which would consume management attention and put the scale thesis in question.
- Net leverage above 2.0x EBITDA, whether from merger financing or otherwise.
Pre-registered UPGRADE conditions — what would take this to Buy — Tactical:
- A price below roughly $170, at which the base case is +22% and the asymmetry moves through 2:1 with no change to any number here. That is 16.5% below spot and just above the 52-week low. This is the cleanest path and it requires nothing from the company.
- Hart-Scott-Rodino clearance of the UniFirst merger without material remedy, together with disclosure of the consideration — which would convert the largest unknown in this dive into a quantifiable event.
- A return to EPS growth above 14%, which would restore the knowledge base's central claim and justify the multiple.
- A seventh consecutive year of operating-margin expansion above 24%.
Where CTAS sits in the Synthos Framework Portfolio. No new position. Where held, hold — a business with this operating record, this return profile and a 0.933 beta is legitimate long-horizon ballast, and nothing in this analysis argues for selling it. On the watch list at $170 for a first tranche of 1.5% in the industrials sleeve. Logged as a tracked Synthos call (Hold) as of 2026-08-04 at $203.65, with the fair-value anchors, kill criteria and upgrade conditions all gradeable. The specific item to grade this dive on is the claim grading in Section 5: 'mid-to-high teens' EPS growth was the knowledge base's central assertion at conviction 90 and it is no longer being delivered, and identifying that is worth more than the price target.
Single biggest risk: the price, and specifically the multiple. At 37.0x the FY2027 consensus for roughly 12% earnings growth, the price-to-earnings-to-growth ratio is above three, the free cash flow yield is 2.31% and the dividend is 0.88%. Every point of return over any horizon must come from earnings growth, because there is no cash yield and no valuation cushion. The observed twelve-month range on the FY2028 estimate is 26.8x to 37.0x, and the stock sits at the very top of it after a 22.0% three-month rally. A de-rating to 30x FY2028 consensus — still a substantial premium and well inside its own annual band — is $183, a 10.1% decline with no deterioration in a business that has not had a bad quarter in six years. That is the shape of the downside here: not a broken company, a re-priced one — and on a name this good, that is the only risk that matters.
Provenance & disclosures
- Traceability: 7 name-level knowledge-base claims name Cintas out of 52,021 distilled claims. Raw hits 7; surviving a case-sensitive entity re-run 7; discarded 0; homograph collisions 0; breadth 7 claims but ONE channel; net conviction unanimous-positive. THE CONCENTRATION IS TOTAL: all seven claims come from a single
business_breakdownsepisode dated 2024-10-22. Remove that one episode and the lane is EMPTY. No concentration sensitivity test is possible because there is nothing to test against, and NO claim in the store post-dates 2024-10-22 — so nothing in the lane reflects the UniFirst merger agreement of 2026-03-10, the leadership change of 2026-08-01, or any of the last twenty-two months. FOUR CLAIMS ARE NOW TESTABLE AND ARE GRADED: (1) 'growing EPS mid-to-high teens' (conviction 90) — PARTIALLY FALSIFIED, diluted EPS grew 11.6% in fiscal 2026, compounded 13.9% over five years, and consensus is 12.0% then 11.2% then 10.6%; (2) 'disciplined ~1x net-debt balance sheet' (85) — CONFIRMED at 0.81x with 24.5x interest coverage; (3) 'over-50% return on operating assets' (85) — CONFIRMED in spirit, with return on equity 41.8%, return on capital employed 33.2% and return on tangible assets 29.9%, though the exact metric is not computable from this file; (4) 'Cintas widened its lead to ~3-4x peers' size... while Vestis/Aramark stayed over-levered' (85) — OVERTAKEN BY EVENTS, because the claim names UniFirst as a peer and Cintas is now buying it, which validates the scale thesis and introduces an antitrust risk no claim in the lane addresses. The remaining three — route density (88), the roughly half-insourced North American market (85) and 96% retention with a ~25-year customer life (80) — are structural descriptions Cintas does not publish data for in any filing in this archive, and are labelled unverified. All seven carryspeaker: nulland are channel-attributed; none is management voice; none is bearish. All quotes are verbatim from the stored claim text. - Data as-of: fundamentals — annual and quarterly statements through 2026-05-31 (fiscal year end), from the 10-K filed 2026-07-29 · estimates 2026-08-04 · prices 2026-08-04, quote timestamp 1785873601 = 2026-08-04T20:00:01Z ($203.65, −0.18%; 50-DMA $184.22; 200-DMA $185.09; RSI 61.6; MACD +7.41) · knowledge-base claims 2026-08-04. Cintas's fiscal year ends 31 May. All figures come from the Synthos vendor data file for CTAS or from the SEC filings in the CTAS archive.
- Filing archive contents: 10-K filed 2026-07-29 (fiscal 2026 — the source of the capital-expenditure series stated both in prose and in the cash flow statement, the segment capital allocation, and the environmental-spending disclosure); 10-Q filed 2026-01-07 (November 2025 quarter); 10-Q filed 2026-04-07 (February 2026 quarter); 8-K filed 2026-06-12 (Item 8.01 — the pending Agreement and Plan of Merger with UniFirst Corporation entered 2026-03-10, through Bruin Merger Sub I, Inc. and Bruin Merger Sub II, LLC, subject to Hart-Scott-Rodino clearance); 8-K filed 2026-07-15 (fourth-quarter and full-year fiscal 2026 results — no extractable Item content in this archive); 8-K filed 2026-08-03 (Item 5.02 — the separation of the President and Chief Executive roles, with Jim Rozakis appointed President and Chief Operating Officer effective 2026-08-01 at a base salary of $900,000, a target cash incentive of $1,125,000 and a target long-term incentive of $4,000,000, while Todd Schneider remains Chief Executive). NO consideration, exchange ratio, closing date or financing arrangement for the UniFirst merger is disclosed anywhere in this archive, so the transaction is NOT sized and NO completion assumption is embedded in any fair-value anchor.
- Where the filings contradicted or corrected the vendor (detailed in Section 6):
seg_geois an EMPTY ARRAY for a company operating across the United States, Canada and Latin America — reported as truncation, with no geographic analysis attempted anywhere in this dive;inc_qreports ZERO depreciation and amortisation for the fourth quarter of fiscal 2026, against $125,937K, $127,501K and $128,670K in the three preceding quarters and $512,846K for the full year incf_a;est.ebitdaAvg/ebitAvg, carrying a fixed-ratio signature of exactly 31.22% and 27.10% of revenue across SEVEN consecutive years (FY2024 to FY2030), with the FY2023 row breaking the pattern at 21.10% and thereby dating the onset, and with the implied EBITDA margin 4.7 points above the reported 26.56%;totalDebtof $2,706.0M, which includes $277.9M of lease obligations (a 10.3% inclusion, immaterial to the leverage conclusion but stated); andresearchAndDevelopmentExpensesreading $0 for fiscal 2026 after $30.8M, $26.6M, $24.5M, $23.5M and $22.3M in the five preceding years. AND, most importantly, the entire UniFirst merger — the largest corporate action on this name — appears in NO field of the payload, which does not even list UniFirst inpeers. Where vendor and filing AGREED — recorded, because these were directed tests: the capital-expenditure check PASSED EXACTLY across three years ($409,469K / $408,884K / $395,105K in both the vendor file and the 10-K cash flow statement, with the 10-K additionally stating the figures in prose), and thecapexToDepreciationTTMdiagnostic of 0.770 reconciles to a direct 0.771, withfreeCashFlowYieldTTMof 2.308% reconciling exactly to our recomputation of $1,881.2M against a $81,494.5M market capitalisation;seg_prodPASSED, summing to $11,264,761,000 against FY2026 revenue to the dollar, in both the current and the prior taxonomy; andkm_ttmandratios_ttmare present and complete. - Basis note: Cintas reports on a GAAP basis and the
earn_calactuals trackinc_qclosely (the June quarter reads $1.29 and $1.26, a 2.4% difference consistent with a modest adjustment), so all multiples in this dive are struck on a consistent basis and no material adjusted-versus-GAAP bridge applies. Free cash flow is recomputed as filed operating cash flow minus filed capital expenditure. - Estimate coverage: 13 analysts on FY2027 EPS with a range of $5.437 to $5.567 — a 2.4% spread, by a wide margin the tightest forward distribution in this batch — and 12 on FY2028, the anchor for all three fair values, with a 5.4% range. 5 on FY2029 and ONE on FY2030, excluded. The tightness is itself informative: thirteen analysts agree almost exactly about a company that has beaten by +1.9%, +0.8%, +0.8%, 0.0% and +4.0% across five quarters, so on this name forward estimates carry more weight than on any other in the batch.
- Peer note: the vendor peer set — CSX, Emerson, Illinois Tool Works, Johnson Controls, Quanta Services, TransDigm, Thomson Reuters, UPS, Vertiv and Waste Management — contains not one uniform-rental or route-based textile-services company, and in particular does NOT include UniFirst, the company Cintas has agreed to acquire, or Vestis, the two names the knowledge base identifies as its direct comparators. Waste Management is the closest structural analogue as a route-density business. No earnings or estimate data for any peer is present in this file, so no peer-multiple comparison is drawn.
- Fair-value caveat: the $155 / $208 / $252 anchors are multiples of the FY2028 consensus EPS distribution — 26.0x the low of $5.96988, 34.0x the mean of $6.11011, and 40.0x the high of $6.30042 — cross-checked against the observed twelve-month multiple range of 26.8x to 37.0x derived from the 52-week low of $163.55 and high of $226.27. Stated arithmetic, not a discounted cash flow. The base assumes MULTIPLE COMPRESSION from 37.0x to 34.0x — giving back three of the roughly eleven turns gained in the 22.0% three-month rally — and at an unchanged 37.0x the fair value is $226, +11.0%, while at 30x it is $183, −10.1%. The entire question on this name is the multiple. No UniFirst completion assumption is embedded in any anchor, because the transaction is not sized in this archive.
- Timing: fourth-quarter and full-year fiscal 2026 results were released 2026-07-15, twenty days before this dive, beating the consensus EPS estimate by 4.0% ($1.29 against $1.24) and revenue by 1.1%. The last five prints show EPS surprises of +1.9%, +0.8%, +0.8%, 0.0% and +4.0%. The next print is 2026-09-23, 50 days away, against a consensus of $1.35 and $2,980,798K. The UniFirst Hart-Scott-Rodino review could resolve at any time. The most recent insider filings are dated 2026-07-28 (three director accruals), and the only open-market sale is 4,363 shares at $199.90 on 2026-07-22 by a director, paired with an option exercise at $27.10. 2026-08-04 carried no company-specific SEC filing; the most recent is the 8-K of 2026-08-03.
- Accessibility note: no information in this dive is conveyed by colour. All emphasis is carried by bold text, table structure and explicit labelling.
- Not investment advice. Independent research, educational and informational only, never personalised. No recommendation to buy, sell or hold any security is made to any person.
- Version: 2026-08-04-full.